Upcoming Events

eLearning Discovery Toxicology: Module 3 Secondary Pharmacology in Drug Discovery Live Today

Discovery Toxicology: An Early Drug Discovery Survival Guide—the NEW eLearning seminar. This seminar introduces the key principles of discovery toxicology, beginning with target identification and the development of a target safety profile through qualitative assessment of desired and undesired effects. It continues with the prediction of potential safety concerns using in silico and in vitro activity profiles, includes a thorough evaluation of secondary pharmacology, and concludes with in vivo studies aimed at understanding and predicting clinical safety to support candidate selection.  

Module 1: On Demand
• Target Safety Assessment

Module 2: On Demand
• How to Customize the Screening Funnel for Safety Assessment

Module 3: April 9, 2026
• Secondary Pharmacology in Drug Discovery

Module 4: May 7, 2026
• Early In Vivo Exploratory and Derisking Studies

Registration Now! Toxicology for Pharmaceutical and Regulatory Scientists Course Begins Next Week

This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. The course includes a mix of lectures with breakout group discussions of regulatory case studies and hands-on analyses of nonclinical data, to give participants the opportunity to apply the concepts of toxicology in the context of drug development. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology. 

🗓️ The course is scheduled for April 20–24, 2026.

Toxicology for Pharmaceutical and Regulatory Scientists Course

This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. The course includes a mix of lectures with breakout group discussions of regulatory case studies and hands-on analyses of nonclinical data, to give participants the opportunity to apply the concepts of toxicology in the context of drug development. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology. 

eLearning Discovery Toxicology: Module 4 Early In Vivo Exploratory and Derisking Studies Live Today

Discovery Toxicology: An Early Drug Discovery Survival Guide—the NEW eLearning seminar. This seminar introduces the key principles of discovery toxicology, beginning with target identification and the development of a target safety profile through qualitative assessment of desired and undesired effects. It continues with the prediction of potential safety concerns using in silico and in vitro activity profiles, includes a thorough evaluation of secondary pharmacology, and concludes with in vivo studies aimed at understanding and predicting clinical safety to support candidate selection.  

Module 1: On Demand
• Target Safety Assessment

Module 2: On Demand
• How to Customize the Screening Funnel for Safety Assessment

Module 3: On Demand
• Secondary Pharmacology in Drug Discovery

Module 4: May 7, 2026
• Early In Vivo Exploratory and Derisking Studies

Signature Webinar: Immunotoxicity Assessment in Drug Development

The last several years have witnessed many advancements within the field of immunotoxicology. These advancements include new therapeutic options to treat inflammatory and autoimmune diseases, identification of new immune targets, mechanisms, and potential safety concerns, and the development of new immunotoxicity assays. The types of immune effects encountered can vary dramatically and present unique challenges during drug development. This session will address the various types of immunotoxicities, and the nonclinical assays and strategies used to address them. An overview of the guidance documents pertinent to nonclinical immunotoxicity assessment will also be included.

SPEAKER: David McMillan, PhD, DABT

Registration Now! Advanced Comprehensive Toxicology Course Begins Next Week

This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. By popular demand, the course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.

🗓️ The course is scheduled for August 10–14, 2026.

Advanced Comprehensive Toxicology Course

This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. By popular demand, the course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.